Global Marek Disease Market, By Type (Diagnosis, Treatment), Clinical Manifestation (Neurological, Visceral, Others), End Users (Hospitals, Specialty Clinics Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Marek Disease Market
Global Marek disease market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR 7.20% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.
However, increasing awareness of Marek disease in poultry-dense countries and regions also boosts up the market growth. Moreover, high-Intensity production facilities of vaccines and higher efficiency offered by recombinant vaccines also boost up the market growth. But, lack of awareness of the infection in developing countries may hamper the global Marek disease market.
Marek disease is a highly contagious viral infection of the poultry identified by peripheral nerve enlargement and T-cell lymphomas. It is a disease of chickens (domestic fowl) caused by a herpesvirus of the genus Mardivirus. Marek disease is highly contagious and readily transmitted among chickens. The common symptoms of this disease include the appearance of paralysis, weight loss, vision impairment, and greyish-white tumours on internal organs. Birds are infected by inhalation of contaminated dust from poultry houses. Till now no specific treatment approved for Marek disease and morbidity is 10-50% and mortality up to 100%.
This Marek disease market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Marek Disease Market Scope and Market Size
The Marek Disease market is segmented on the basis of type, clinical manifestation, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the Marek disease market is segmented into diagnosis and treatment. Diagnosis segment is further divided into histopathology, virus isolation, antigen detection, real-time qPCR, immune response test (AGID, IFA and others). Treatment segment is further divided into vaccination and others. Vaccination further divided into recombinant, toxoid, live attenuated, conjugated and others.
- On the basis of clinical manifestation, the Marek disease market is segmented into neurological, visceral and others.
- On the basis of end users, the Marek disease market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the Marek disease market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Marek Disease Market Country Level Analysis
Marek disease market is analysed and market size information is provided by country, type, clinical manifestation, end users and distribution channel as referenced above.
The countries covered in the Marek disease market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to the presence of development to provide genetic resistance through vaccines and biosecurity programs. Europe accounts the second largest market share due to increased refined healthcare facilities. Asia-Pacific is expected to account for the largest market share over coming years for the Marek disease market due to increased advancement in the technology as well as growing healthcare expenditure and rising awareness program.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Marek disease market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Marek Disease Market Share Analysis
Marek disease market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Marek disease market.
The major players covered in the Marek disease market are Merck & Co., Inc., Pfizer Inc., Virbac, Bayer Healthcare, Sanofi-Aventis U.S., Boehringer Ingelheim among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
